Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
International Journal of Surgery (London, England)|March 28, 2023
Patterns and prognostic values of programmed cell death-ligand 1 expression and CD8 + T-cell infiltration in small cell carcinoma of the esophagus: a retrospective analysis of 34 years of National Cancer Center data in ChinaChaoqi Zhang, Guochao Zhang, Liyan Xue, et al.
Clinical and Translational Medicine|July 14, 2020
Combined detection of aneuploid circulating tumor-derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non-small-cell lung cancerYuanyuan Lei, Nan Sun, Guochao Zhang, et al.
Cancer Medicine|June 28, 2020
Development and validation of an immune-related prognostic signature in lung adenocarcinomaSijin Sun, Wei Guo, Zhen Wang, et al.
World Journal of Surgery|March 21, 2025
Computed Tomography-Guided Radiofrequency Ablation Combined With Video-Assisted Thoracoscopic Surgery for Multiple Pulmonary Nodules: A Retrospective Study From the National Cancer Center in ChinaLong Zhang, Guochao Zhang, Ruifeng Xu, et al.
Journal of Cancer Research and Clinical Oncology|May 20, 2021
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in ChinaGuochao Zhang, Chaoqi Zhang, Nan Sun, et al.
DNA and Cell Biology|February 26, 2020
Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and BioinformaticsWei Guo, Sijin Sun, Lei Guo, et al.
Journal of Cancer Research and Clinical Oncology|February 28, 2020
Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformaticsWei Guo, Sijin Sun, Lei Guo, et al.
Journal of Immunology Research|August 8, 2022
Intratumoral IL-28B Gene Delivery Elicits Antitumor Effects by Remodeling of the Tumor Microenvironment in H22-Bearing MiceZhi Li, Jianghua Wang, Chong Chen, et al.
The Annals of Thoracic Surgery|February 6, 2026
Surgical and Survival Benefits of Neoadjuvant Targeted Therapy versus Chemoimmunotherapy in Lung Adenocarcinoma: A Dual-center ResearchJiaxi Xu, Kun Wang, Guochao Zhang, et al.
Medcomm|February 12, 2026
Clinical Benefit of PD-1/PD-L1 Inhibitors as Standard First-Line Treatment in Low PD-L1-Expressing Advanced Solid Tumors: A Systematic Review and Meta-AnalysisPeng Wu, Xuanyu Gu, Dongyu Li, et al.
Pageof 16